MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
Neoleukin Therapeutics Shares 2011-2026 | NLTX
Annual Shares Neoleukin Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 492 K | 55.2 M | 55 M | 54.1 M | 27 M | 23.5 M | 23.5 M | 18.9 M | 12.6 M | 8.67 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 55.2 M | 492 K | 27.9 M |
Quarterly Shares Neoleukin Therapeutics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21.2 M | 21.1 M | 21 M | 14.9 M | 17 M | 16.9 M | 16.9 M | 12.8 M | 446 K | 444 K | 55.4 M | 8.53 M | 11.1 M | 55.2 M | 55.1 M | 42.5 M | 55.1 M | 55 M | 54.9 M | 42.2 M | 54.1 M | 49.4 M | 49.2 M | 38 M | 26.2 M | 23.5 M | 23.5 M | 23.5 M | 23.5 M | 23.5 M | 23.5 M | 23.5 M | 23.5 M | 23.4 M | 23.4 B | 23.4 M | 17.7 M | 17.2 M | 17.2 M | 17.2 M | 11.8 M | 10.7 M | 10.7 M | 10.7 M | 10.7 M | 10.7 M | 3.15 M | 302 K | 302 K | 302 K | 302 K | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 23.4 B | 302 K | 482 M |
Shares of other stocks in the Drug manufacturers industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alimera Sciences
ALIM
|
25.6 M | - | - | $ 142 M |  USA |
 |
Aerie Pharmaceuticals
AERI
|
46.3 M | - | - | $ 754 M | USA |
 |
Canopy Growth Corporation
CGC
|
108 M | $ 1.14 | -1.72 % | $ 123 M |  Canada |
 |
AcelRx Pharmaceuticals
ACRX
|
25.8 M | - | 7.5 % | $ 6.35 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
150 M | - | 0.86 % | $ 117 M | USA |
 |
Cronos Group
CRON
|
350 M | $ 2.63 | 0.19 % | $ 1.38 B | Canada |
 |
Catalent
CTLT
|
181 M | - | - | $ 11.5 B | USA |
 |
Agile Therapeutics
AGRX
|
2.16 M | - | 10.11 % | $ 58.2 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
42.7 M | - | - | $ 55.5 M | USA |
 |
Aurora Cannabis
ACB
|
169 M | $ 4.22 | -0.94 % | $ 86.3 M | Canada |
 |
DURECT Corporation
DRRX
|
26.3 M | - | - | $ 50.1 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
12.9 M | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
235 M | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
3.34 M | - | - | $ 36.6 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
50.8 M | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
127 M | - | 2.45 % | $ 38.1 M | Canada |
 |
Emergent BioSolutions
EBS
|
51.2 M | $ 12.36 | 1.64 % | $ 633 M | USA |
 |
Athenex
ATNX
|
6.54 M | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
95.1 M | $ 21.55 | 0.05 % | $ 2.05 B |  France |
 |
Evolus
EOLS
|
62 M | $ 6.65 | -0.3 % | $ 412 M | USA |
 |
Harrow Health
HROW
|
32.6 M | $ 49.0 | -2.04 % | $ 1.6 B | USA |
 |
China Pharma Holdings
CPHI
|
17.5 M | $ 1.21 | -9.02 % | $ 21.1 M |  China |
 |
Organogenesis Holdings
ORGO
|
132 M | $ 5.18 | - | $ 682 M | USA |
 |
OrganiGram Holdings
OGI
|
256 M | $ 1.68 | -1.18 % | $ 402 M | Canada |
 |
Pacira BioSciences
PCRX
|
46.2 M | $ 25.88 | -0.73 % | $ 1.2 B | USA |
 |
Bausch Health Companies
BHC
|
365 M | $ 6.95 | -0.57 % | $ 2.54 B | Canada |
 |
Lannett Company
LCI
|
40.4 M | - | 1.15 % | $ 7.11 M | USA |
 |
Rockwell Medical
RMTI
|
23.3 M | $ 0.83 | 2.18 % | $ 19.4 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
14.1 M | $ 3.98 | 0.51 % | $ 56 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
1.24 M | $ 3.64 | 0.64 % | $ 4.52 M | USA |
 |
Sundial Growers
SNDL
|
1.86 M | $ 1.66 | 0.61 % | $ 3.37 M | Canada |
 |
PetIQ
PETQ
|
29.1 M | - | 1.64 % | $ 400 M | USA |
 |
Jupiter Wellness
JUPW
|
54.4 M | - | - | $ 33.6 M | USA |
 |
Veru
VERU
|
135 M | $ 2.14 | -1.38 % | $ 289 M | USA |
 |
Perrigo Company plc
PRGO
|
137 M | $ 13.92 | -0.14 % | $ 1.91 B | USA |
 |
ProPhase Labs
PRPH
|
15.8 M | $ 0.45 | -1.28 % | $ 7.13 M | USA |
 |
Radius Health
RDUS
|
47.2 M | - | - | $ 1.42 B | USA |
 |
cbdMD
YCBD
|
4.31 M | $ 1.35 | -0.37 % | $ 5.82 M | USA |
 |
Recro Pharma
REPH
|
95.2 M | - | -4.76 % | $ 65.3 M | USA |
 |
Relmada Therapeutics
RLMD
|
30.1 M | $ 4.83 | 6.62 % | $ 145 M | USA |
 |
OptiNose
OPTN
|
112 M | - | - | $ 1.08 B | USA |
 |
Assertio Holdings
ASRT
|
71 M | $ 9.07 | -1.41 % | $ 644 M | USA |
 |
PLx Pharma
PLXP
|
23.7 M | - | -27.8 % | $ 2.56 M | USA |
 |
Solid Biosciences
SLDB
|
40.8 M | $ 5.64 | -1.05 % | $ 230 M | USA |
 |
SCYNEXIS
SCYX
|
47.9 M | $ 0.63 | 4.43 % | $ 30.1 M | USA |
 |
Tricida
TCDA
|
51.3 M | - | - | $ 3.25 M | USA |
 |
Tilray
TLRY
|
618 M | $ 9.03 | 0.11 % | $ 5.58 B | Canada |
 |
TherapeuticsMD
TXMD
|
10.4 M | $ 1.63 | -0.61 % | $ 17 M | USA |
 |
Viatris
VTRS
|
1.21 B | $ 12.45 | -0.72 % | $ 15.1 B | USA |